HER2 Positive Advanced Solid Tumors
4 clinical trials · Condition
◉ Watch HER2 Positive Advanced Solid Tumors
| Record | Firm | Date |
|---|---|---|
| SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors (NCT05245058) | Shanghai Pharmaceuticals Holding Co., Ltd | 2022-01-21 |
| A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms (NCT03219268) | MacroGenics | 2017-08-18 |
Track HER2 Positive Advanced Solid Tumors automatically
Every clearance here is in the API, with alerts when new ones post.